Literature DB >> 2014801

A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene.

R H Lekanne Deprez1, N A Groen, N A van Biezen, A Hagemeijer, E van Drunen, J W Koper, C J Avezaat, D Bootsma, E C Zwarthoff.   

Abstract

Cytogenetic analysis of meningioma cells from one particular patient (MN32) displayed the stem-line karyo-type 45, XY, -1, 4p+, 22q-, 22q+, which thus had rearrangements of both chromosomes 22. The 22q+ marker appeared as a dicentric: 22 pter----q11::1p11----qter. The reciprocal product of this translocation has presumably been lost because it lacked a centromere. The 22q- chromosome also appeared to have lost sequences distal to band q11. We assumed that this marker could have been the result of a reciprocal translocation between chromosomes 4 and 22. To investigate the 4p+ and 22q- chromosomes in more detail, human-hamster somatic cell hybrids were constructed that segregated the 22q- and 4p+ chromosomes. Southern blot analysis with DNA from these hybrids showed that sequences from 22q were indeed translocated to 4p+ and that reciprocally sequences from 4p were translocated to 22q-, demonstrating a balanced t(4;22)(p16;q11). On the basis of these results we presume that in this tumor a tumor-suppressor gene is deleted in the case of the 22q+ marker and that the t(4;22) disrupts the second allele of this gene. The latter translocation was mapped between D22S1 and D22S15, a distance of 1 cM on the linkage map of this chromosome. The area in which we have located the translocation is within the region where the gene predisposing to neurofibromatosis 2 has been mapped.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2014801      PMCID: PMC1682947     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  46 in total

1.  Cytological and cytogenetical studies on human meningioma.

Authors:  K D Zang
Journal:  Cancer Genet Cytogenet       Date:  1982-07

2.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

3.  Structural organization of the bcr gene and its role in the Ph' translocation.

Authors:  N Heisterkamp; K Stam; J Groffen; A de Klein; G Grosveld
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

4.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Risk factors for meningiomas in men in Los Angeles County.

Authors:  S Preston-Martin; M C Yu; B E Henderson; C Roberts
Journal:  J Natl Cancer Inst       Date:  1983-05       Impact factor: 13.506

6.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA.

Authors:  D Barker; M Schafer; R White
Journal:  Cell       Date:  1984-01       Impact factor: 41.582

7.  Chromosome abnormalities in meningiomas.

Authors:  J Katsuyama; P R Papenhausen; F Herz; P Gazivoda; A Hirano; L G Koss
Journal:  Cancer Genet Cytogenet       Date:  1986-05

8.  Case-control study of intracranial meningiomas in women in Los Angeles County, California.

Authors:  S Preston-Martin; A Paganini-Hill; B E Henderson; M C Pike; C Wood
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

9.  The human v-abl cellular homologue.

Authors:  N Heisterkamp; J Groffen; J R Stephenson
Journal:  J Mol Appl Genet       Date:  1983

10.  Organization of the human myoglobin gene.

Authors:  P Weller; A J Jeffreys; V Wilson; A Blanchetot
Journal:  EMBO J       Date:  1984-02       Impact factor: 11.598

View more
  10 in total

1.  Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation.

Authors:  Ayten Kandilci; Gerard C Grosveld
Journal:  Blood       Date:  2009-06-26       Impact factor: 22.113

2.  Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

3.  Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.

Authors:  R H Lekanne Deprez; A B Bianchi; N A Groen; B R Seizinger; A Hagemeijer; E van Drunen; D Bootsma; J W Koper; C J Avezaat; N Kley
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

4.  Gain-of-Function MN1 Truncation Variants Cause a Recognizable Syndrome with Craniofacial and Brain Abnormalities.

Authors:  Noriko Miyake; Hidehisa Takahashi; Kazuyuki Nakamura; Bertrand Isidor; Yoko Hiraki; Eriko Koshimizu; Masaaki Shiina; Kazunori Sasaki; Hidefumi Suzuki; Ryota Abe; Yayoi Kimura; Tomoko Akiyama; Shin-Ichi Tomizawa; Tomonori Hirose; Kohei Hamanaka; Satoko Miyatake; Satomi Mitsuhashi; Takeshi Mizuguchi; Atsushi Takata; Kazuyuki Obo; Mitsuhiro Kato; Kazuhiro Ogata; Naomichi Matsumoto
Journal:  Am J Hum Genet       Date:  2019-12-12       Impact factor: 11.025

5.  Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.

Authors:  L Papi; L R De Vitis; F Vitelli; F Ammannati; P Mennonna; E Montali; U Bigozzi
Journal:  Hum Genet       Date:  1995-03       Impact factor: 4.132

6.  Identification of the first intragenic deletion of the PITX2 gene causing an Axenfeld-Rieger Syndrome: case report.

Authors:  Guillaume de la Houssaye; Ivan Bieche; Olivier Roche; Véronique Vieira; Ingrid Laurendeau; Laurence Arbogast; Hatem Zeghidi; Philippe Rapp; Philippe Halimi; Michel Vidaud; Jean-Louis Dufier; Maurice Menasche; Marc Abitbol
Journal:  BMC Med Genet       Date:  2006-11-29       Impact factor: 2.103

7.  Pathogenesis of vestibular schwannoma in ring chromosome 22.

Authors:  Ellen Denayer; Hilde Brems; Paul de Cock; Gareth D Evans; Frank Van Calenbergh; Naomi Bowers; Raf Sciot; Maria Debiec-Rychter; Joris V Vermeesch; Jean-Pierre Fryns; Eric Legius
Journal:  BMC Med Genet       Date:  2009-09-22       Impact factor: 2.103

8.  Deletion mapping of chromosome 1p and 22q in pheochromocytoma.

Authors:  E Shin; S Fujita; K Takami; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1993-04

9.  Allogeneic stem cell transplantation mitigates the adverse prognostic impact of high diagnostic BAALC and MN1 expression in AML.

Authors:  Madlen Jentzsch; Marius Bill; Juliane Grimm; Dominic Brauer; Donata Backhaus; Karoline Goldmann; Julia Schulz; Dietger Niederwieser; Uwe Platzbecker; Sebastian Schwind
Journal:  Ann Hematol       Date:  2020-08-29       Impact factor: 3.673

10.  MN1 overexpression with varying tumor grade is a promising predictor of survival of glioma patients.

Authors:  Masum Saini; Ajaya Nand Jha; Rajiv Tangri; Md Qudratullah; Sher Ali
Journal:  Hum Mol Genet       Date:  2021-01-06       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.